Novartis5h
Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
Novartis19h
Return on investment calculator
This tool allows you to determine the current value and the yield of a given amount of stock invested in the past. Fill in the amount invested or amount of the stock, as well as the purchase date, in ...
Novartis20h
Zaposlitev v Novartisu v Sloveniji
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Novartis22h
Nové pracovní příležitosti
Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Pro další pozice ve společnosti Novartis Gene Therapies (dříve AveXis) navštivte GTx Hledání práce. Drug Product Technologies ...